<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40400686</article-id><article-id pub-id-type="pmc">PMC12092438</article-id><article-id pub-id-type="doi">10.3389/fmicb.2025.1582851</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Epidemiology and resistance mechanisms of tigecycline- and carbapenem-resistant <italic>Enterobacteriaceae</italic> in China: a multicentre genome-based study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yan</surname><given-names>Lixin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn0008" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ma</surname><given-names>Tingting</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="fn0008" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wen</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>Zhen</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1399397/overview"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Hong</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/86470/overview"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Zhongju</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Renru</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Yan</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Gang</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2295627/overview"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Jia</surname><given-names>Wei</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2791081/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Tao</surname><given-names>Jia</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1452447/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>The First Clinical Medical College of Ningxia Medical University</institution>, <addr-line>Yinchuan</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Laboratory Medical Center, General Hospital of Ningxia Medical University</institution>, <addr-line>Yinchuan</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Ningxia Key Laboratory of Clinical and Pathogenic Microbiology</institution>, <addr-line>Yinchuan</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Clinical Laboratory, Aviation General Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University</institution>, <addr-line>Suzhou</addr-line>, <country>China</country></aff><aff id="aff6"><sup>6</sup><institution>Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution>, <addr-line>Wuhan, Hubei</addr-line>, <country>China</country></aff><aff id="aff7"><sup>7</sup><institution>Institute of Antibiotics, Huashan Hospital, Fudan University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><aff id="aff8"><sup>8</sup><institution>Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0009"><p>Edited by: Yasser Mahmmod, Long Island University, United States</p></fn><fn fn-type="edited-by" id="fn0010"><p>Reviewed by: Okon Okwong Kenneth, Federal University, Wukari, Nigeria</p><p>Jun Sung Hong, Silla University, Republic of Korea</p></fn><corresp id="c001">*Correspondence: Wei Jia, <email>Jiawei220803@163.com</email>; Jia Tao, <email>taojia880625@163.com</email></corresp><fn fn-type="equal" id="fn0008"><p><sup>&#x02020;</sup>These authors have contributed equally to this work and share first authorship</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>1582851</elocation-id><history><date date-type="received"><day>25</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Yan, Ma, Wang, Cai, Du, Chen, Han, Guo, Li, Jia and Tao.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Yan, Ma, Wang, Cai, Du, Chen, Han, Guo, Li, Jia and Tao</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec id="sec1"><title>Objectives</title><p>To elucidate the molecular epidemiology of tigecycline and carbapenem-resistant <italic>Enterobacteriaceae</italic> isolates and mechanisms of tigecycline resistance.</p></sec><sec id="sec2"><title>Methods</title><p>We gathered 31 unduplicated strains of tigecycline-resistant <italic>Enterobacteriaceae</italic> from six hospitals nationwide. Antimicrobial susceptibility testing, phenotypic detection, and PCR identification were performed first, followed by homology analysis using MLST and PFGE. Conjugation transfer experiments using resistance gene plasmids were carried out, and the conjugates&#x02019; growth curves were examined. All strains were sequenced using the Illumina HiSeq technology, and we identified a strain KP28 carrying a complete gene cluster <italic>tmexCD2-toprJ2</italic>. Then, its plasmid was further constructed using the PacBio platforms to complete the frame. The genetic connection of the <italic>tmexCD2-toprJ2</italic> gene cluster carried by KP28 was established using core genome analyses.</p></sec><sec id="sec3"><title>Results</title><p>All 31 tigecycline-resistant <italic>Enterobacteriaceae</italic> strains (TG-CRE) were multidrug resistant. PFGE classified strains of CRKP, CRECL, and CRKAE into 16 distinct spectra, 6 distinct spectra, and 3 distinct spectra. MLST results showed a high concentration of ST11 in CRKP strains and a predominance of ST116 in CRECL strains, suggesting possible clonal transmission or selective dominance. The findings of the plasmid conjugation assay revealed that three strains expressing carbapenem resistance genes were effectively transmitted to the recipient cell <italic>E. coli</italic> EC600. WGS data revealed that these 31 strains include 79 resistance genes, with one strain (KP28) carrying the whole tigecycline resistance gene cluster, <italic>tmexC2D2-toprJ2</italic>. This resistance gene is contained in a large IncHI5 plasmid, which is difficult to transfer.</p></sec><sec id="sec4"><title>Conclusion</title><p>The overall carriage rate of the <italic>tmexC2D2-toprJ2</italic> gene cluster was found to be low among the five Chinese hospitals investigated. Conversely, <italic>tet</italic>(A) mutations were present in most of the strains. Bacteria with the carbapenem resistance genes <italic>bla</italic><sub>KPC</sub> and <italic>bla</italic><sub>NDM</sub> are vulnerable to horizontal transmission. Increasing the risk of transmission of antibiotic-resistant genes.</p></sec></abstract><kwd-group><kwd>CRE</kwd><kwd>tigecycline resistance</kwd><kwd>genemic analysis</kwd><kwd><italic>tmexCD2-toprJ2</italic></kwd><kwd><italic>tet</italic>(A)</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. The study was supported by Key Research and Development Project of Ningxia Hui Autonomous Region (2023BEG03046) and Natural Science Foundation of Ningxia Hui Autonomous Region (2022AAC03542).</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="1"/><equation-count count="0"/><ref-count count="38"/><page-count count="11"/><word-count count="6774"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Antimicrobials, Resistance and Chemotherapy</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5"><label>1</label><title>Introduction</title><p>With a high global morbidity and mortality rate and few available treatments, carbapenem-resistant <italic>Enterobacteriaceae</italic> (CRE) infections have emerged as a major public health concern (<xref rid="ref29" ref-type="bibr">van Duin, 2017</xref>). The third-generation antibiotic in the tetracycline family, tigecycline, has a wider spectrum of action against both Gram-positive and Gram-negative bacteria that are extensively drug-resistant (XDR) (<xref rid="ref6" ref-type="bibr">Chopra and Roberts, 2001</xref>). For the treatment of CRE infection, tigecycline is now considered a last-resort antibiotic. According to an international ESCMID cross-sectional survey, the most popular treatment for patients with CRE-caused skin and soft-tissue infections, as well as intra-abdominal infections, is tigecycline monotherapy (<xref rid="ref23" ref-type="bibr">Papst et al., 2018</xref>). <xref rid="ref3" ref-type="bibr">Brust et al. (2014)</xref> reported a favorable outcome in the treatment of CRE urinary tract infection with high dose tigecycline. However, recently reported studies have revealed the emergence of tigecycline resistance in CRE strains from humans and animals worldwide (<xref rid="ref5" ref-type="bibr">Chiu et al., 2017</xref>; <xref rid="ref8" ref-type="bibr">Cui et al., 2021</xref>; <xref rid="ref15" ref-type="bibr">Hirabayashi et al., 2021</xref>). Tigecycline resistance has become a serious concern and poses a major threat to public health.</p><p>Tigecycline reversibly binds to the 30S subunit of bacterial ribosomes, inhibiting the extension of the peptide chain, thus preventing bacterial protein translation (<xref rid="ref35" ref-type="bibr">Yaghoubi et al., 2022</xref>). To date, several mechanisms associated with resistance to tigecycline have been reported (<xref rid="ref21" ref-type="bibr">Korczak et al., 2024</xref>). The most commonly reported mechanism in Gram-negative bacteria is the increased expression of efflux pump families. Resistance-nodulation-cell division (RND) efflux pump is the most important molecular mechanism in the resistance to tigecycline, such as AcrAB, <italic>tmexCD1-toprJ1</italic>, <italic>tmexCD2-toprJ2</italic> and OqxAB (<xref rid="ref35" ref-type="bibr">Yaghoubi et al., 2022</xref>). The expression of the AcrAB efflux pump is controlled by several transcriptional activators of the AraC/XylS family, such as RamA, MarA, RarA, and SoxS, which can increase the production of AcrAB proteins and enhancing efflux by interacting with the acrAB promoter (<xref rid="ref25" ref-type="bibr">Ruzin et al., 2008</xref>; <xref rid="ref31" ref-type="bibr">Veleba et al., 2012</xref>). These transcriptional activators are regulated by themselves as trans-acting repressors. Overproduction of another RND efflux system, OqxAB, is also regulated by the local repressor OqxR (<xref rid="ref9" ref-type="bibr">De Majumdar et al., 2013</xref>). Mobile gene cluster <italic>tmexCD-toprJ</italic> is a kind of plasmid-located RND efflux pump genes and has been found to be carried by different plasmid types. <italic>TmexCD-toprJ</italic> complexes function as efflux pumps for tigecycline that could confer resistance to tigecycline (<xref rid="ref22" ref-type="bibr">Liu et al., 2022</xref>). In addition, mutations of other genes, such as <italic>tet</italic>(A), <italic>rpsJ</italic>, <italic>adeS</italic>, <italic>rpoB</italic>, and <italic>rrf</italic>, have been reported to be associated with decreased tigecycline susceptibility (<xref rid="ref16" ref-type="bibr">Hua et al., 2021</xref>; <xref rid="ref34" ref-type="bibr">Xu et al., 2021</xref>; <xref rid="ref13" ref-type="bibr">He et al., 2018</xref>).</p><p>Recently, tigecycline resistance with multiple mechanisms has raised a major concern worldwide. This study aimed to investigate the phenotypic characteristics, molecular epidemiology, and mechanisms of tigecycline resistance in CRE isolates from six hospitals in China.</p></sec><sec sec-type="materials|methods" id="sec6"><label>2</label><title>Materials and methods</title><sec id="sec7"><label>2.1</label><title>Bacterial isolate collection and identification</title><p>A total of 31 unduplicated tigecycline-and carbapenem-resistant <italic>Enterobacteriaceae</italic> (CRE) strains were collected from six hospitals across Beijing, Shanghai, Wuhan, Suzhou, Chengdu, and Yinchuan in China between January and April 2023. All of the samples and clinical isolates were generated as part of routine hospital laboratory procedures. The distribution of specimen types was mostly sputum (48.3%, 14/29), followed by urine (24.1%, 7/29), pus (17.2%, 5/29), blood (6.9%, 2/29), and cerebrospinal fluid (3.5%, 1/29). All strains were identified using MALDI-TOF-MS (bioM&#x000e9;rieux, France), confirming that all bacteria included in the study were members of the <italic>Enterobacteriaceae</italic> family. The distribution of bacterial strains was dominated by <italic>Klebsiella pneumoniae</italic> (64.52%, 20/31), followed by <italic>Enterobacter cloacae</italic> (25.80%, 8/31) and <italic>Enterobacter aerogenes</italic> (9.68%, 3/31). To identify carbapenemase production in all CRE strains, the enzyme inhibitor-enhanced assay (PBA-EDTA method) was employed (<xref rid="ref27" ref-type="bibr">Tsakris et al., 2010</xref>). PCR amplification was utilized to detect four common carbapenemase-encoding genes: <italic>bla</italic><sub>KPC</sub>, <italic>bla</italic><sub>IMP</sub>, <italic>bla</italic><sub>NDM</sub>, and <italic>bla</italic><sub>OXA-48</sub> (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table S1</xref>), followed by Sanger sequencing and analyzed using BLAST<xref rid="fn0001" ref-type="fn"><sup>1</sup></xref> (<xref rid="ref26" ref-type="bibr">Tian et al., 2023</xref>). Approval by Institutional Review Board or Institutional Animal Care and Use Committee was not required because our research was not involved with human subjects or animal experimentation.</p></sec><sec id="sec8"><label>2.2</label><title>Antimicrobial susceptibility testing (AST)</title><p>According to the Clinical and Laboratory Standards Institute (CLSI) guidelines, an antimicrobial susceptibility test was performed using the VITEK&#x000ae; 2 Compact to determine MICs of piperacillin/tazobactam, ceftazidime, cefepime, aztreonam, imipenem, meropenem, amikacin, ciprofloxacin, levofloxacin. All antimicrobials were interpreted according to the standard of the CLSI document (<xref rid="ref7" ref-type="bibr">Clinical and Laboratory Standard Institute, 2010</xref>). The MICs for tigecycline (MCE, China) were assessed by the broth microdilution method with MH broth (Solaibao, Beijing) in accordance with the Food and Drug Administration breakpoints criteria (FDA, &#x02264;2.0&#x0202f;mg/L is susceptible, 4.0&#x0202f;mg/L is intermediate, and&#x02265;8.0&#x0202f;mg/L is resistant) (<xref rid="ref28" ref-type="bibr">US FDA, 2013</xref>). <italic>Escherichia coli</italic> ATCC 25922 was used as a quality control strain for antimicrobial susceptibility testing. Tigecycline-resistant and carbapenem-resistant <italic>Enterobacteriaceae</italic> (TG-CRE) was defined if <italic>Enterobacteriaceae</italic> was resistant to both at least one carbapenem [imipenem (MIC &#x02265; 4.0&#x0202f;mg/L) and/or meropenem (MIC &#x02265; 4.0&#x0202f;mg/L)] and tigecycline (MIC &#x02265; 8.0&#x0202f;mg/L).</p></sec><sec id="sec9"><label>2.3</label><title>Multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE)</title><p>MLST and PFGE were used to determine the genetic relatedness among the 20 carbapenem-resistant <italic>Klebsiella pneumoniae</italic> (CRKP) and 8 carbapenem-resistant <italic>Enterobacter cloacae</italic> (CRECL) isolates. The analysis focused on seven housekeeping genes from <italic>Klebsiella pneumoniae</italic> (<italic>gapA, infB, mdh, pgi, phoE, rpoB,</italic> and <italic>tonB</italic>) and seven housekeeping genes from <italic>Enterobacter cloacae</italic> (<italic>dnaA, fusA, gyrB, leuS, pyrG, rplB</italic>, and <italic>rpoB</italic>) (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table S2</xref>). Following polymerase chain reaction (PCR) amplification and Sanger sequencing, the PUBMLST database<xref rid="fn0002" ref-type="fn"><sup>2</sup></xref> was accessed for gene sequence comparison. A single gene sequence number was obtained, which facilitated the determination of the corresponding allele sequence number, ultimately allowing for the identification of the sequence type (ST) of the tested strains (<xref rid="ref4" ref-type="bibr">Chavda et al., 2016</xref>). For pulsed-field gel electrophoresis (PFGE), small gel blocks were prepared from overnight cultured bacteria. These gel blocks containing bacterial DNA were then cleaved using QuickCut (Rad, USA), and PFGE was conducted on XbaI-digested genomic DNA. The gel was stained for 30&#x0202f;min with Gelred 0.5&#x0202f;mg/mL, and then the fingerprinting profile was observed by the Uvitec system by illuminated UV wave to the gel. <italic>Salmonella enterica</italic> serotype Braenderup strain (H9812) was used as a classical molecular weight standard. The PFGE profiles were compared using In silico stimulation of molecular experiment with a dice similarity coefficient and UPGMA analysis to create the dendrogram. To analyze genetic relatedness, cut-off line at 85% was considered. Data visualization was conducted using BioNumerics version 8.0 software (<xref rid="ref24" ref-type="bibr">Park et al., 2020</xref>).</p></sec><sec id="sec10"><label>2.4</label><title>Conjugation experiments and bacterial growth curving</title><p>To investigate the potential for horizontal transfer of drug-resistance genes to other bacteria, we utilized rifampin-resistant <italic>E. coli</italic> EC600 as the recipient strain, while all samples served as donor strains for conjugation experiments. Single colonies of both donor and recipient bacteria were selected and inoculated into 2&#x0202f;mL of LB broth, followed by incubation on a shaking platform at 37&#x000b0;C for 6&#x0202f;h. Subsequently, 500&#x0202f;&#x003bc;L of both donor and recipient cultures were transferred into 4&#x0202f;mL of LB broth and incubated overnight at 37&#x000b0;C. The cultured bacterial solution was diluted, and 100&#x0202f;&#x003bc;L was applied using an L-shaped inoculating loop onto a double-drug MacConkey plate containing 4&#x0202f;&#x003bc;g/mL tigecycline (Meropenem) and 100&#x0202f;&#x003bc;g/mL rifampicin, followed by incubation for 24&#x0202f;h to select for transconjugants. Concurrently, EC600 was streaked and inoculated on a rifampicin plate as a control. To observe the growth of the transconjugants, they were cultured in 3&#x0202f;mL of LB medium at 200&#x0202f;rpm and 37&#x000b0;C overnight. After adjusting the optical density (OD600) to 0.25, the culture was continued. Every hour, 200&#x0202f;&#x003bc;L was aspirated and replaced with 200&#x0202f;&#x003bc;L of LB medium in a 96-well plate, and the OD600 was measured. This detection process lasted for 24&#x0202f;h, with three duplicate wells for each strain, and C600 served as the control strain (<xref rid="ref17" ref-type="bibr">Huang et al., 2023</xref>). Growth curves were generated using GraphPad.</p></sec><sec id="sec11"><label>2.5</label><title>Whole genome sequencing and analysis</title><p>The DNA in the clinical isolates was extracted by grinding with liquid nitrogen, incubating, cooling at room temperature, centrifuging the supernatant and adding an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) and mixing with shaking, then centrifuging the supernatant and adding isopropanol and 100&#x0202f;&#x003bc;L of sodium acetate in 2/3 of the volume of the supernatant and mixing, and then precipitating for 2&#x0202f;h at &#x02212;20&#x000b0;C, centrifuging to remove the supernatant and adding 1&#x0202f;mL of 75% ethanol, and centrifuging again to dissolve the precipitate with TE for second-generation short fragment extraction. After centrifugation again, the precipitate was dissolved with TE for second-generation short fragment extraction, and the magnetic bead method was used to extract the long fragment DNA of the tissue.</p><p>The whole genome sequences were sequenced using the Illumina HiSeq platform (San Diego, CA, USA) for all the 31 TG-CRE isolates. <italic>K. pneumoniae</italic> isolate KP28 carrying <italic>tmexC2D2-toprJ2</italic> was subjected to whole-genome sequencing (WGS) using both short-read (Illumina, San Diego, CA, USA) and long-read (PacBio, Menlo Park, CA, USA) platforms. Clean Data was assembled using SPAdes (v3.9.0) assembly software, and the optimal assembly results of each sample were obtained after multiple adjustments. Then, reads will align to the assembled Contig, and the optimization of assemble results would be done through the overlap of the pair end of the reads and Contig. The presence of antimicrobial resistance genes (ARGs) was identified utilizing the CARD (<xref rid="ref18" ref-type="bibr">Jia et al., 2017</xref>) and ResFinder 4.6.0 server<xref rid="fn0003" ref-type="fn"><sup>3</sup></xref>. The NCBI database&#x02019;s ORFfinder tool<xref rid="fn0004" ref-type="fn"><sup>4</sup></xref> was used to predict the open reading frame present in plasmid 1 of KP28. The BLAST Ring Image Generator (BRIG) v0.95 was employed to generate circular comparisons among the plasmids carrying the <italic>tmexCD-toprJ</italic> genes, with the results visually represented by concentric rings (<xref rid="ref1" ref-type="bibr">Alikhan et al., 2011</xref>). The EasyFig v2.2.3 software was employed to conduct a comparative analysis of the genetic backgrounds of the strains. All identified <italic>tet</italic>(A) variants protein sequences were aligned with MEGA software, and cluster heatmap of <italic>tet</italic>(A) variants protein was depicted by ChiPlot<xref rid="fn0005" ref-type="fn"><sup>5</sup></xref>. The structure-based sequences alignments and 2D structure were performed using ESPript<xref rid="fn0006" ref-type="fn"><sup>6</sup></xref>. Phylogenetic trees were generated using kSNP3.0 (<xref rid="ref10" ref-type="bibr">Gardner et al., 2015</xref>) and then beautified by iTOL v6<xref rid="fn0007" ref-type="fn"><sup>7</sup></xref>.</p></sec></sec><sec sec-type="results" id="sec12"><label>3</label><title>Results</title><sec id="sec13"><label>3.1</label><title>Clinical and microbiological characteristics of all strains</title><p>In 2023, we collected 31 tigecycline-resistant CREs from six hospitals in China, including 16 strains (51.6%) from Suzhou Province, 7 strains (22.6%) from Ningxia Province, 4 strains (12.9%) from Sichuan Province, 2 strains (6.45%) from Beijing Province, 1 strains (3.225%) from Shanghai and 1 strains (3.225%) from Wuhan. Carbapenem phenotyping experiments showed that the number of serinase-producing strains in class A was 13 (42.0%, 13/31), metalloenzyme-producing strains in class B was 9 (29.0%, 9/31), and 9 strains of both enzymes were non-producing (29.0%, 9/31). PCR and Sanger sequencing related results showed that there were 14 strains (45.2%, 14/31) CRE carrying <italic>bla</italic><sub>KPC</sub> gene, and all of them were <italic>bla</italic><sub>KPC-2</sub> typed, 9 strains (29.0%, 9/31) of CRE carrying <italic>bla</italic><sub>NDM</sub> gene, and the typing included 3 strains of <italic>bla</italic><sub>NDM-1</sub> gene and 6 strains of <italic>bla</italic><sub>NDM-5</sub> gene. One CRE strain each (3.2%, 1/31) carried <italic>bla</italic><sub>IMP</sub> and <italic>bla</italic><sub>OXA-48</sub> genes. It can be seen that all strains are Multidrug-resistant bacteria (MDR), sensitive to only a few drugs (<xref rid="tab1" ref-type="table">Table 1</xref>). The specific resistance profile was Piperacillin/tazobactam (100%, 31/31), Ceftazidime (100%, 31/31), Cefepime (96.8%, 30/31), Aztreonam (87.1%, 27/31), Imipenem (100%, 31/31), Meropenem (87.1%, 27/31), and Piperacillin/tazobactam (100%, 31/31), Meropenem (87.1%, 27/34), Amikacin (25.8%, 8/31), Ciprofloxacin (74.2%, 23/31), Levofloxacin (77.4%, 24/31) and tigecycline (100%, 31/31).</p><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>Antimicrobial susceptibility testing of TG-CRE, and transconjugants that received the Carbapenem resistance genes of <italic>bla</italic><sub>KPC</sub> or <italic>bla</italic><sub>NDM</sub>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Strain(s)</th><th align="center" valign="top" colspan="10" rowspan="1">MIC (mg/L)<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></th></tr><tr><th rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">TZP</th><th align="center" valign="top" rowspan="1" colspan="1">CAZ</th><th align="center" valign="top" rowspan="1" colspan="1">FEP</th><th align="center" valign="top" rowspan="1" colspan="1">ATM</th><th align="center" valign="top" rowspan="1" colspan="1">IPM</th><th align="center" valign="top" rowspan="1" colspan="1">MEM</th><th align="center" valign="top" rowspan="1" colspan="1">AMK</th><th align="center" valign="top" rowspan="1" colspan="1">CIP</th><th align="center" valign="top" rowspan="1" colspan="1">LVX</th><th align="center" valign="top" rowspan="1" colspan="1">TGC</th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="11" rowspan="1">Clinical isolates</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP20</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">4R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EC25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">1S</td><td align="center" valign="middle" rowspan="1" colspan="1">16I</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP27</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP28</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;1R</td><td align="center" valign="middle" rowspan="1" colspan="1">1S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP31</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">29S</td><td align="center" valign="middle" rowspan="1" colspan="1">1S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">32R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP32</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KA33</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP34</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">16S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP36</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP37</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP38</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EC39</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">8S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP43</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP46</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="middle" rowspan="1" colspan="1">1R</td><td align="center" valign="middle" rowspan="1" colspan="1">1I</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP47</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP50</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KA53</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="middle" rowspan="1" colspan="1">2I</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP54</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP57</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP58</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">2R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td><td align="center" valign="middle" rowspan="1" colspan="1">2I</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">4R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP59</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">KP60</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="middle" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">KA61</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;64/R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">4S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td><td align="center" valign="top" rowspan="1" colspan="1">4R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">KP62</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">1R</td><td align="center" valign="top" rowspan="1" colspan="1">4R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;8S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;4R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;8R</td><td align="center" valign="top" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">KP63</td><td align="center" valign="top" rowspan="1" colspan="1">64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">2S</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;4R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;8R</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EC67</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EC68</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="top" rowspan="1" colspan="1">18R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">11R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">1I</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EC78</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">10R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">1 I</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EC81</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">10R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">1 I</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EC89</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">6R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">1I</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EC90</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;32R</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td><td align="center" valign="top" rowspan="1" colspan="1">32I</td><td align="center" valign="top" rowspan="1" colspan="1">2I</td><td align="center" valign="top" rowspan="1" colspan="1">4R</td><td align="center" valign="top" rowspan="1" colspan="1">16R</td></tr><tr><td align="left" valign="top" colspan="11" rowspan="1">Recipients</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>E. coli</italic> C600</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;4S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">0.5S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.125</td></tr><tr><td align="left" valign="top" colspan="11" rowspan="1">Transconjugants</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C600/KP46-2<xref rid="tfn2" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">0.5S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.125</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C600/KP54-1<xref rid="tfn3" ref-type="table-fn"><sup>c</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;128R</td><td align="center" valign="top" rowspan="1" colspan="1">16R</td><td align="center" valign="top" rowspan="1" colspan="1">4R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">0.5S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.125</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C600/KP63<xref rid="tfn2" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;64R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;1S</td><td align="center" valign="top" rowspan="1" colspan="1">8R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;16R</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;2S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.25S</td><td align="center" valign="top" rowspan="1" colspan="1">0.5S</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02264;0.125</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>a</label><p>TZP, Piperacillin-tazobactam; CAZ, Ceftazidime; FEP, Cefepime; AT-M, Aztreonam; IPM, Imipenem; MEM, Meropenem; AMK, Amikacin; CIP, Ciprofloxac-in; LVX, Levof-loxacin; TGC, Tigecycline.</p></fn><fn id="tfn2"><label>b</label><p>
<italic>blaNDM-positive transconjugant of E. coli C600, selected by using 100&#x0202f;&#x003bc;g/mL rifampin and 4&#x0202f;&#x003bc;g/mL meropenem.</italic>
</p></fn><fn id="tfn3"><label>c</label><p>
<italic>blaKPC-positive transconjugant of E. coli C600, selected by using 100&#x0202f;&#x003bc;g/mL rifampin an-d 4&#x0202f;&#x003bc;g/mL meropenem.</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec14"><label>3.2</label><title>Molecular epidemiology based on MLST and PFGE</title><p>Gel electrophoresis with pulsed fields PFGE classified strains of CRKP, CRECL, and CRKAE into 16 distinct spectra, 6 distinct spectra, and 3 distinct spectra, respectively. Strains from the same region were more likely to have the same spectra; for example, KP38, KP47, and KP37 from Suzhou had the same spectra, and KP31 and KP32 from Chengdu had the same spectra. MLST results revealed that ST11 type dominated CRKP strains with 60% (12/20), followed by ST15 (15%, 3/20), one strain each of ST967, ST1958, ST45, ST485, and ST17, and CRECL strains were dominated by ST116 type (50%, 4/8), followed by ST1226, ST74, ST70, and one strain each of ST270 (<xref rid="fig1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>PFGE-based dendrogram of TG-CRE strains. Strain numbers, strain types, source of initial isolation, department, region and carbapenemase are included along each PFGE lane. MLST, multilocus sequence typing; &#x0201c;-&#x0201d;, not detected.</p></caption><graphic xlink:href="fmicb-16-1582851-g001" position="float"/></fig></sec><sec id="sec15"><label>3.3</label><title>Conjugation assay and fitness cost</title><p>Strains carrying tigecycline resistance genes cannot be transferred to the recipient cell <italic>E. coli</italic> EC600 through plasmid conjugation, however, three strains harboring carbapenem resistance genes, namely KP46, KP54, and KP63, can be successfully transferred. The conjugation frequency was measured at (5.25&#x0202f;&#x000b1;&#x0202f;2.06)&#x0202f;&#x000d7;&#x0202f;10^-6. Consequently, we evaluated the impact of plasmid acquisition on biological adaptability and found a significant difference in the growth rate of <italic>E. coli</italic> EC600 related to plasmid acquisition within the time frame of 4 to 24&#x0202f;h (<italic>p</italic> &#x0003c;&#x0202f;0.05, <xref rid="fig2" ref-type="fig">Figure 2</xref>). Stability assays indicated that both the plasmids and their associated resistance genes remained stable in the conjugates after 12 passages without antibiotic selection. Additionally, the antimicrobial susceptibility profiles of translocants containing these plasmids are presented in <xref rid="tab1" ref-type="table">Table 1</xref>.</p><fig position="float" id="fig2"><label>Figure 2</label><caption><p>Growth curves of <italic>E. coli</italic> EC600 and the transformants. Values represent the means &#x000b1; standard deviations obtained from three independent repeated experiments. A repeated measures two-way analysis of variance (ANOVA) with Tukey&#x02019;s multiple comparisons was used to evaluate statistical significance.</p></caption><graphic xlink:href="fmicb-16-1582851-g002" position="float"/></fig></sec><sec id="sec16"><label>3.4</label><title>Identification of antimicrobial resistance genes</title><p>Resistance genes were predicted from whole genome sequencing data, and the 31 strains contained a total of 79 resistance genes (<xref rid="fig3" ref-type="fig">Figure 3</xref>), including carbapenem resistance genes (<italic>bla</italic><sub>NDM-1</sub>, <italic>bla</italic><sub>NDM-5</sub>, and <italic>bla</italic><sub>KPC-2</sub>), ESBL genes, quinolone resistance genes, fluoroquinolone resistance genes, aminoglycoside resistance genes, trimethoprim-like resistance genes, and chloramphenicol resistance genes, macrolide antibiotic resistance genes, tetracycline resistance genes, rifampicin resistance genes and phosphinic acid-sulfonamide-lincomycin resistance genes, and one additional strain, KP28, was found to carry the complete <italic>tmexC2-tmexD2-TOprJ2</italic> tigecycline resistance gene cluster. Sequence comparison of the 21 <italic>tet</italic>(A)-positive strains with the original reference sequence X00006 (GenBank: X00006.1) in the NCBI database revealed that all strain isolates were characterized by non-synonymous mutations in I5R, V55M, I75V, T84A, S201A, F202S, and V203F, and in addition, individual strains had specific mutations, for example, KP62 had I235F, KA33 had A371V, and KP31 had V14L (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure S1</xref>).</p><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Distribution of antimicrobial resistance genes in 31 TG-CREs.</p></caption><graphic xlink:href="fmicb-16-1582851-g003" position="float"/></fig></sec><sec id="sec17"><label>3.5</label><title>Genome feature and genetic contexts of the KP28</title><p>We further sequenced KP28 using the PacBio platform. The genome measured 5,725,141 bp and contained a 5,311,350 bp chromosome as well as two circular plasmids: plasmid pKP28-1 (357,673 bp) and plasmid pKP28-2 (56,118 bp). The IncHI5 plasmid pKP28-1 has 370 predicted open reading frames (ORFs), including a <italic>tmexC2D2-toprJ2</italic> gene cluster, three <italic>&#x003b2;</italic>-lactamase genes (<italic>bla</italic><sub>IMP-4,</sub>
<italic>bla</italic><sub>SFO-1</sub>, and <italic>bla</italic><sub>TEM-1B</sub>), three aminoglycoside resistance genes (<italic>aph(3&#x02033;)-Ib, aph(6)-Id</italic>, and <italic>aac(3)-IId</italic>), and one macrolide antibiotic resistance gene [<italic>mph(A)</italic>]. BLASTn analysis found that three human IncHI plasmids (pJNQH473-3, pJNQH491-2, and pNUITM) had comparable backbones to pKP28-1 and included the <italic>tmexC2D2-toprJ2</italic> gene (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). However, none of the three plasmids contain the <italic>bla</italic><sub>IMP-4</sub> gene. There was no conjugative transfer system discovered in pKP28-1, which may explain why they were not successfully transferred into <italic>E. coli</italic> EC600 or <italic>E. coli</italic> J53 in our conjugation experiment.</p><fig position="float" id="fig4"><label>Figure 4</label><caption><p><bold>(A)</bold> Comparative structural analysis of <italic>tmexCD-toprJ</italic>-carrying plasmids pKP28 in this study. <bold>(B)</bold> The genetic context of the <italic>tmexCD2-toprJ2</italic> gene cluster and related mobile elements. pHNNC189-2 (MN175502) and Tn<italic>6855</italic> (MK347425) from the NCBI database were selected as references.</p></caption><graphic xlink:href="fmicb-16-1582851-g004" position="float"/></fig><p>To comprehensively comprehend the differences in neighboring genetic elements and the genetic environment of <italic>tmexC2D2-toprJ2</italic>, we selected plasmid pHNNC189-2 (GenBank: MN175502) and transposon Tn<italic>6855</italic> (GenBank: MK347425) from the NCBI database as references. Our analysis revealed that the <italic>tnfxB2-tmexCD2-toprJ2</italic> cluster is located within the relevant region of Tn<italic>6855</italic> and highly coincided with the corresponding region of strain <italic>Raoultella ornithinolytica</italic> plasmid pHNNC189-2 (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). In contrast to Tn<italic>6855</italic>, the transposon gene tnpA, which encodes transposase, is inserted into the pKP28-1 gene <italic>tnfxB2</italic> in the plasmid of <italic>K. pneumoniae</italic>. Tn<italic>6855</italic> and its variants are predominantly found in <italic>Klebsiella pneumoniae</italic> plasmids and <italic>Raoultella ornithinolytica</italic> plasmids, however, the fundamental mechanism underlying the spread of Tn<italic>6855</italic> remains unclear. Further research is warranted.</p></sec><sec id="sec18"><label>3.6</label><title>Possible origin of <italic>tnfxB</italic>2-<italic>tmexC2D2-toprJ2</italic></title><p>To elucidate the origin and evolutionary relationship of the <italic>tnfxB2-tmexCD2-toprJ2</italic> RND drug efflux complex, we conducted a search of the NCBI genome database for strains containing the <italic>mexCD-oprJ</italic> and <italic>tmexCD-toprJ</italic> gene clusters. This search revealed that 113 strains contained the <italic>mexCD-oprJ</italic> gene cluster, while 8,120 strains contained the <italic>tmexCD-toprJ</italic> gene cluster. Applying the criteria that each strain&#x02019;s uploaded sequence exceeds 200&#x0202f;kb and fully covers the <italic>mexCD-oprJ</italic> or <italic>tmexCD-toprJ</italic> gene, we screened 43 strains. The resulting neighbor-joining tree places <italic>tmexC2D2-toprJ2</italic> within a phylogenetic group characterized by high amino acid identity (&#x0003e;90%) (<xref rid="fig5" ref-type="fig">Figure 5</xref>). Notably, the <italic>tmexCD2-toprJ2</italic> gene is predominantly located in <italic>Klebsiella</italic> and <italic>Raoultella</italic> species. The phylogenetic tree indicates that the variant KP28-<italic>tmexCD2-toprJ2</italic> identified in this study is highly similar to CP096266.1, which was isolated from Zhengzhou, China, in 2022, as recorded in the NCBI database. This similarity suggests a potential risk of transfer and transmission between the two variants (<xref rid="fig5" ref-type="fig">Figure 5</xref>). Additionally, most <italic>mexCD-oprJ</italic> and <italic>tmexCD-toprJ</italic> variants were found in plasmids, highlighting the role of plasmids as significant intermediaries that carry gene clusters facilitating transmission between bacteria. Previous studies have established that <italic>mexCD-oprJ</italic> variants generally emerge earlier than <italic>tmexCD-toprJ</italic> variant (<xref rid="ref1" ref-type="bibr">Alikhan et al., 2011</xref>). Our findings suggest that <italic>tmexCD2-toprJ2</italic> will likely evolve from <italic>tmexCD1-toprJ1</italic>, while <italic>tmexCD3-toprJ</italic> is distantly related.</p><fig position="float" id="fig5"><label>Figure 5</label><caption><p>Phylogenetic tree of the <italic>tmexCD-toprJ</italic> gene clusters. The different background colors of the sequence IDs indicate the related variants of <italic>mexCD-oprJ</italic>.</p></caption><graphic xlink:href="fmicb-16-1582851-g005" position="float"/></fig></sec></sec><sec sec-type="discussion" id="sec19"><label>4</label><title>Discussion</title><p>Over the past two decades, carbapenem-resistant <italic>Enterobacteriaceae</italic> (CRE) have emerged as a major challenge in hospital infections globally (<xref rid="ref11" ref-type="bibr">Giacobbe et al., 2024</xref>). These bacteria gain resistance primarily by acquiring carbapenemase genes, which enable them to break down carbapenems, a class of antibiotics (<xref rid="ref2" ref-type="bibr">Alizadeh et al., 2020</xref>). Plasmid-mediated carbapenemases are a key factor in this resistance development, allowing the rapid spread of resistance genes among different bacterial species (<xref rid="ref30" ref-type="bibr">van Duin and Doi, 2017</xref>). Tigecycline, a last-resort antibiotic for treating extensively drug-resistant bacteria, is facing threats from emerging resistance mechanisms (<xref rid="ref14" ref-type="bibr">He et al., 2019</xref>). In 2019, He et al. identified plasmid-mediated high-level mobility of tigecycline resistance genes <italic>tet</italic>(X3) and <italic>tet</italic>(X4). Additionally, there have been cases where <italic>tet</italic>(X) coexists with other resistance genes like <italic>tmexCD3-toprJ3</italic> and <italic>bla</italic><sub>NDM-4</sub> in <italic>Enterobacteriaceae</italic> (<xref rid="ref15" ref-type="bibr">Hirabayashi et al., 2021</xref>). This highlights the limited treatment options available when patients become infected with this type of bacteria.</p><p>In this study, we conducted a comprehensive microbiological characterization of 31 tigecycline-resistant, carbapenem-resistant <italic>Enterobacteriaceae</italic> (TG-CRE) strains collected from multiple hospitals in China. Our findings indicate that all the strains are multidrug-resistant (MDR), with some even exhibiting extensive drug resistance. It is particularly noteworthy that strains carrying tigecycline resistance genes cannot be transferred to recipient cells via plasmid conjugation, whereas strains harboring carbapenem resistance genes can be successfully transferred, with a relatively high frequency of conjugation. This observation suggests that tigecycline resistance genes may be transmitted through other mechanisms, such as chromosomal mutations or plasmid integration, while carbapenemresistance genes are more likely to be disseminated through conjugation. Furthermore, strains that acquire resistance plasmids exhibit significant differences in biological adaptability, which may influence their survival and propagation in the natural environment. The MLST typing in this study revealed that <italic>Klebsiella pneumoniae</italic> was dominated by ST11 (60%), followed by ST15. The results were consistent with the overall epidemic situation in China. <italic>Enterobacter cloacae</italic> was mainly composed of ST116 (50%), which was different from the previously reported ST418 type in China (<xref rid="ref19" ref-type="bibr">Jin et al., 2018</xref>). PFGE further confirmed that the strains from the same region (such as KP37, KP38, and KP47 from Suzhou) had high homology, suggesting a high degree of clonal transmission within the hospital or region. The isolates from different cities were less related to each other. In this work, conjugation techniques were used to successfully transfer the <italic>bla</italic><sub>KPC</sub> and <italic>bla</italic><sub>NDM</sub> genes from the donor <italic>Klebsiella pneumoniae</italic> to <italic>E. coli</italic> EC600. The persistence of the plasmids and the conjugants&#x02019; resistance to carbapenems suggested that CRE might disseminate the resistance by plasmid-level transmission, despite the conjugation efficiency being relatively low. Notably, the conjugants carrying plasmids showed a loss in growth adaptability, which is in line with the &#x0201c;cost of adaptation&#x0201d; theory put forward in earlier research. Through compensating changes, the resistant plasmids may restore their adaptive advantage, but their long-term durability under natural settings may be limited. We must be more vigilant in order to stop the spread.</p><p>This study identified 79 resistance genes through whole-genome sequencing and drug resistance gene prediction, including known carbapenem resistance genes such as <italic>bla</italic><sub>KPC-2</sub>, <italic>bla</italic><sub>NDM-1,</sub> and <italic>bla</italic><sub>NDM-5</sub>, as well as a variety of other categories of drug resistance genes, which aligns with previous drug susceptibility results. Literature indicates that mutations in the tetracycline resistance gene <italic>tet</italic>(A) can confer resistance to tigecycline (<xref rid="ref5" ref-type="bibr">Chiu et al., 2017</xref>). In this study, 21 strains were identified based on the reference sequence of the <italic>E. coli</italic> plasmid RP1 tetracycline resistance determinant (GenBank:X00006). All TG-CRE isolates carrying the <italic>tet</italic>(A) gene exhibited non-synonymous mutations, specifically 5R, V55M, I75V, T84A, S201A, F202S, and V203F, including double frame-shifting mutations (S201A, F202S, V203F). This finding is consistent with the analysis by <xref rid="ref38" ref-type="bibr">Zhang et al. (2023)</xref>, suggesting that these mutations may bea primary factor contributing to the resistance observed in these strains. Particular attention was given to the IncHI5-like hybrid plasmid found in one of the low-level tigecycline-resistant CRKP isolates, which co-carried <italic>tmexC2D2-toprJ2</italic> and <italic>bla</italic><sub>IMP-4</sub> but was unable to undergo successful conjugative transfer. The presence of the transcriptional repressor <italic>tnfxB</italic>2 may have contributed to this low level of horizontal resistance. Linear comparison analysis revealed that <italic>tnfxB2-tmexC2D2-toprJ2</italic> is situated within a specific region of transposon Tn<italic>6855.</italic> However, it is noteworthy that the <italic>tnpA</italic> gene is inserted between <italic>tnfxB2</italic> and <italic>tmexC</italic>2. The <italic>tnpA</italic> gene, a common genetic marker found in certain transposons (Tn), encodes a transposase. This enzyme can specifically recognize the DNA sequences at both ends of the receptor target and Tn, facilitating the integration of Tn into the target sequence (<xref rid="ref20" ref-type="bibr">Karvelis et al., 2021</xref>). Tn<italic>6855</italic> is a prototype integrative and mobilizable element (IME) that includes attL/R (attachment sites at the left and right ends), two genes encoding putative site-specific integrases (int1 and int2), four hypothetical protein genes, and the <italic>nfxB-mexCD-oprJ</italic> cluster, as previously described (<xref rid="ref37" ref-type="bibr">Yu et al., 2021</xref>). It is hypothesized that the Tn<italic>6855</italic> variant identified in this study likely originates from a plasmid of <italic>Raoultella ornithinolytica</italic>. However, the specific transmission mechanism has yet to be investigated. In 2019, large IncFIB (Mar)/IncHI1B and IncHI5-like hybrid plasmids, along with the IncFrepB (R1701) plasmid co-carrying carbapenemase-encoding genes (<italic>bla</italic><sub>IMP-4,</sub>
<italic>bla</italic><sub>NDM-1</sub>, and <italic>bla</italic><sub>KPC-2</sub>) and <italic>tmexCD-toprJ</italic>, were reported. However, unlike the IncFrepB (R1701) plasmid, these large plasmids exhibited no conjugation effect on either <italic>E. coli</italic> or <italic>K. pneumoniae</italic> (<xref rid="ref12" ref-type="bibr">Guo et al., 2024</xref>), which accounts for the failure of conjugation. Nevertheless, the evolution of plasmids presents potential clinical risks that warrant our close attention.</p><p>In our study, the sequences collected from the NCBI database revealed that the bacterial genera harboring the <italic>tmexCD1-toprJ1</italic> and <italic>tmexCD2-toprJ2</italic> gene clusters were predominantly <italic>Klebsiella</italic>, while the bacterial genera containing the <italic>tmexCD3-toprJ1</italic> gene cluster were primarily Pseudomonas. Notably, most of the <italic>tmexCD-toprJ</italic> gene clusters are located on plasmids, suggesting a significant risk of interspecies transfer upon entering <italic>Enterobacteriaceae</italic>. The <italic>tmexCD2-toprJ2</italic> gene cluster may have originated from the chromosome of Pseudomonas (<xref rid="ref32" ref-type="bibr">Wang et al., 2021</xref>) and exhibits a high nucleotide similarity to <italic>tmexCD1-toprJ1</italic>. However, it possesses a weaker promoter, <italic>tmexC2</italic>, and a repressor factor, <italic>tnfxB</italic>2 (<xref rid="ref33" ref-type="bibr">Wang et al., 2024</xref>), which correlates with lower resistance levels. <italic>Klebsiella pneumoniae</italic> associated with the <italic>tmexCD2-toprJ2</italic> gene cluster is globally distributed across various environments and hosts, with the majority of isolates originating from China. This indicates that China plays a crucial role in the dissemination of the global <italic>tmexCD2-toprJ2</italic> gene cluster (<xref rid="ref36" ref-type="bibr">Yao et al., 2024</xref>). Our sample size is limited, preventing us from making specific statistical inferences about the positivity rate in the region. We have only conducted preliminary explorations of the resistance mechanisms of all strains. Additionally, unreported variants of <italic>tet</italic>(A) necessitate further construction of vectors to verify their resistance.</p></sec><sec sec-type="conclusions" id="sec20"><label>5</label><title>Conclusion</title><p>Our study is part of a multi-center investigation and has revealed the emergence of carbapenem-resistant <italic>Enterobacteriaceae</italic> that are resistant to tigecycline, a last-resort antibiotic, in hospitals across multiple regions. This finding was confirmed through whole-genome sequencing analysis. Most strains examined carry mutants of the <italic>tet</italic>(A) gene, which substantiates the mechanism behind tigecycline resistance. Notably, only one CRKP strain was found to carry the <italic>tmexCD-toprJ</italic> gene cluster, suggesting that its overall incidence remains relatively low. However, strains harboring the <italic>bla</italic><sub>KPC</sub> and <italic>bla</italic><sub>NDM</sub> carbapenem resistance genes have the potential for horizontal transmission. To date, clonal transmission of the <italic>tmexCD2-toprJ2</italic> and the <italic>bla</italic><sub>IMP-4</sub> co-carried plasmid IncHI5 has not been observed. Given the increasing use of tigecycline in the treatment of clinical CRE infections, ongoing surveillance is essential.</p></sec></body><back><fn-group><fn id="fn0001"><p>
<sup>1</sup>
<ext-link xlink:href="https://blast.ncbi.nlm.nih.gov/blast.cgi" ext-link-type="uri">https://blast.ncbi.nlm.nih.gov/blast.cgi</ext-link>
</p></fn><fn id="fn0002"><p>
<sup>2</sup>
<ext-link xlink:href="https://pubmlst.org/bigsdb?db=pubmlst_mlst_seqdef&#x00026;page=batchSequenceQuery" ext-link-type="uri">https://pubmlst.org/bigsdb?db=pubmlst_mlst_seqdef&#x00026;page=batchSequenceQuery</ext-link>
</p></fn><fn id="fn0003"><p>
<sup>3</sup>
<ext-link xlink:href="http://genepi.food.dtu.dk/resfinder" ext-link-type="uri">http://genepi.food.dtu.dk/resfinder</ext-link>
</p></fn><fn id="fn0004"><p>
<sup>4</sup>
<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/orffinder/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/orffinder/</ext-link>
</p></fn><fn id="fn0005"><p>
<sup>5</sup>
<ext-link xlink:href="https://www.chiplot.online/" ext-link-type="uri">https://www.chiplot.online/</ext-link>
</p></fn><fn id="fn0006"><p>
<sup>6</sup>
<ext-link xlink:href="http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi" ext-link-type="uri">http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi</ext-link>
</p></fn><fn id="fn0007"><p>
<sup>7</sup>
<ext-link xlink:href="https://itol.embl.de/" ext-link-type="uri">https://itol.embl.de/</ext-link>
</p></fn></fn-group><sec sec-type="data-availability" id="sec21"><title>Data availability statement</title><p>The original contributions presented in the study are included in the article/<xref rid="SM1" ref-type="supplementary-material">Supplementary material</xref>, further inquiries can be directed to the corresponding authors.</p></sec><sec sec-type="author-contributions" id="sec22"><title>Author contributions</title><p>LY: Data curation, Methodology, Software, Writing &#x02013; original draft. TM: Validation, Visualization, Writing &#x02013; review &#x00026; editing. WW: Data curation, Writing &#x02013; review &#x00026; editing. ZCa: Resources, Writing &#x02013; review &#x00026; editing. HD: Resources, Writing &#x02013; review &#x00026; editing. ZCh: Resources, Writing &#x02013; review &#x00026; editing. RH: Resources, Writing &#x02013; review &#x00026; editing. YG: Resources, Writing &#x02013; review &#x00026; editing. GL: Resources, Writing &#x02013; review &#x00026; editing. WJ: Funding acquisition, Project administration, Resources, Writing &#x02013; review &#x00026; editing. JT: Funding acquisition, Validation, Visualization, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="sec24"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="sec25"><title>Generative AI statement</title><p>The authors declare that no Gen AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="sec26"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="sec27"><title>Supplementary material</title><p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2025.1582851/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2025.1582851/full#supplementary-material</ext-link></p><supplementary-material id="SM1" position="float" content-type="local-data"><media xlink:href="Data_Sheet_1.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alikhan</surname><given-names>N. F.</given-names></name><name><surname>Petty</surname><given-names>N. K.</given-names></name><name><surname>Ben Zakour</surname><given-names>N. L.</given-names></name><name><surname>Beatson</surname><given-names>S. A.</given-names></name></person-group> (<year>2011</year>). <article-title>BLAST ring image generator (BRIG): simple prokaryote genome comparisons</article-title>. <source>BMC Genomics</source>
<volume>12</volume>:<fpage>402</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2164-12-402</pub-id>, PMID: <pub-id pub-id-type="pmid">21824423</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizadeh</surname><given-names>N.</given-names></name><name><surname>Ahangarzadeh Rezaee</surname><given-names>M.</given-names></name><name><surname>Samadi Kafil</surname><given-names>H.</given-names></name><name><surname>Hasani</surname><given-names>A.</given-names></name><name><surname>Soroush Barhaghi</surname><given-names>M. H.</given-names></name><name><surname>Milani</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Evaluation of resistance mechanisms in Carbapenem-resistant Enterobacteriaceae</article-title>. <source>Infect. Drug Resist.</source>
<volume>13</volume>, <fpage>1377</fpage>&#x02013;<lpage>1385</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S244357</pub-id>, PMID: <pub-id pub-id-type="pmid">32494169</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brust</surname><given-names>K.</given-names></name><name><surname>Evans</surname><given-names>A.</given-names></name><name><surname>Plemmons</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline</article-title>. <source>J. Antimicrob. Chemother.</source>
<volume>69</volume>, <fpage>2875</fpage>&#x02013;<lpage>2876</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dku185</pub-id>, PMID: <pub-id pub-id-type="pmid">24879666</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavda</surname><given-names>K. D.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Fouts</surname><given-names>D. E.</given-names></name><name><surname>Sutton</surname><given-names>G.</given-names></name><name><surname>Brinkac</surname><given-names>L.</given-names></name><name><surname>Jenkins</surname><given-names>S. G.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Comprehensive genome analysis of Carbapenemase-producing Enterobacter spp.: new insights into phylogeny, population structure, and resistance mechanisms</article-title>. <source>MBio</source>
<volume>7</volume>. doi: <pub-id pub-id-type="doi">10.1128/mBio.02093-16</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>S.-K.</given-names></name><name><surname>Huang</surname><given-names>L.-Y.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Tsai</surname><given-names>Y.-K.</given-names></name><name><surname>Liou</surname><given-names>C.-H.</given-names></name><name><surname>Jung-Chung Lin</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Roles of ramR and tet(A) mutations in conferring Tigecycline resistance in Carbapenem-resistant <italic>Klebsiella pneumoniae</italic> clinical isolates</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>61</volume>:<fpage>e00391-17</fpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00391-17</pub-id><pub-id pub-id-type="pmid">28533243</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>I.</given-names></name><name><surname>Roberts</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance</article-title>. <source>Microbiol. Mol. Biol. Rev.</source>
<volume>65</volume>, <fpage>232</fpage>&#x02013;<lpage>260</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MMBR.65.2.232-260.2001</pub-id>, PMID: <pub-id pub-id-type="pmid">11381101</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab id="coll1">Clinical and Laboratory Standard Institute</collab></person-group> (<year>2010</year>). <source>Performance standards for antimicrobial susceptibility testing; twentieth informational supplement</source>. <publisher-loc>Wayne, Pennsylvania</publisher-loc>: <publisher-name>CLSI Document M100-S20</publisher-name>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>C. Y.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Jia</surname><given-names>Q. L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>X. T.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Evolutionary trajectory of the Tet(X) family: critical residue changes towards high-level Tigecycline resistance</article-title>. <source>mSystems</source>
<volume>6</volume>:<fpage>e00050-21</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mSystems.00050-21</pub-id>, PMID: <pub-id pub-id-type="pmid">34006624</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Majumdar</surname><given-names>S.</given-names></name><name><surname>Veleba</surname><given-names>M.</given-names></name><name><surname>Finn</surname><given-names>S.</given-names></name><name><surname>Fanning</surname><given-names>S.</given-names></name><name><surname>Schneiders</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Elucidating the regulon of multidrug resistance regulator RarA in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>57</volume>, <fpage>1603</fpage>&#x02013;<lpage>1609</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01998-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23318802</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>S. N.</given-names></name><name><surname>Slezak</surname><given-names>T.</given-names></name><name><surname>Hall</surname><given-names>B. G.</given-names></name></person-group> (<year>2015</year>). <article-title>kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome</article-title>. <source>Bioinformatics</source>
<volume>31</volume>, <fpage>2877</fpage>&#x02013;<lpage>2878</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btv271</pub-id><pub-id pub-id-type="pmid">25913206</pub-id>
</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacobbe</surname><given-names>D. R.</given-names></name><name><surname>Di Pilato</surname><given-names>V.</given-names></name><name><surname>Vena</surname><given-names>A.</given-names></name><name><surname>Marchese</surname><given-names>A.</given-names></name><name><surname>Bassetti</surname><given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>Interpreting the results of rapid molecular diagnostic tests for carbapenem-resistant Enterobacterales infection: current clinical perspective while waiting for further evidence</article-title>. <source>Expert. Rev. Mol. Diagn.</source>
<volume>24</volume>, <fpage>583</fpage>&#x02013;<lpage>590</lpage>. doi: <pub-id pub-id-type="doi">10.1080/14737159.2024.2383851</pub-id>, PMID: <pub-id pub-id-type="pmid">39054637</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>C.</given-names></name><name><surname>Yuye</surname><given-names>W.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>Global genomic epidemiology and transmission dynamics of plasmid-borne tmexCD-toprJ-carrying <italic>Klebsiella pneumoniae</italic> in a one health context</article-title>. <source>Sci. Total Environ.</source>
<volume>953</volume>:<fpage>176065</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.scitotenv.2024.176065</pub-id>, PMID: <pub-id pub-id-type="pmid">39244063</pub-id>
</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing <italic>Klebsiella pneumoniae</italic> during tigecycline treatment</article-title>. <source>Infect. Genet. Evol.</source>
<volume>66</volume>, <fpage>188</fpage>&#x02013;<lpage>191</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.meegid.2018.09.025</pub-id><pub-id pub-id-type="pmid">30268919</pub-id>
</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Walsh</surname><given-names>T. R.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Lv</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans</article-title>. <source>Nat. Microbiol.</source>
<volume>4</volume>, <fpage>1450</fpage>&#x02013;<lpage>1456</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-019-0445-2</pub-id>, PMID: <pub-id pub-id-type="pmid">31133751</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirabayashi</surname><given-names>A.</given-names></name><name><surname>Dao</surname><given-names>T. D.</given-names></name><name><surname>Takemura</surname><given-names>T.</given-names></name><name><surname>Hasebe</surname><given-names>F.</given-names></name><name><surname>Trang</surname><given-names>L. T.</given-names></name><name><surname>Thanh</surname><given-names>N. H.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>A transferable IncC-IncX3 hybrid plasmid Cocarrying Bla(NDM-4), tet(X), and tmexCD3-toprJ3 confers resistance to Carbapenem and Tigecycline</article-title>. <source>mSystems</source>
<volume>6</volume>:<fpage>e0059221</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mSphere.00592-21</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Novel tigecycline resistance mechanisms in <italic>Acinetobacter baumannii</italic> mediated by mutations in adeS, rpoB and rrf</article-title>. <source>Emerg. Microbes Infect.</source>
<volume>10</volume>, <fpage>1404</fpage>&#x02013;<lpage>1417</lpage>. doi: <pub-id pub-id-type="doi">10.1080/22221751.2021.1948804</pub-id>, PMID: <pub-id pub-id-type="pmid">34170209</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Yi</surname><given-names>M.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Emergence of Tigecycline and Carbapenem-resistant <italic>Citrobacter freundii</italic> co-carrying tmexCD1-toprJ1, blaKPC-2, and blaNDM-1 from a Sepsis patient</article-title>. <source>Infect. Drug Resist.</source>
<volume>16</volume>, <fpage>5855</fpage>&#x02013;<lpage>5868</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S426148</pub-id>, PMID: <pub-id pub-id-type="pmid">37692469</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>B.</given-names></name><name><surname>Raphenya</surname><given-names>A. R.</given-names></name><name><surname>Alcock</surname><given-names>B.</given-names></name><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>Guo</surname><given-names>P.</given-names></name><name><surname>Tsang</surname><given-names>K. K.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database</article-title>. <source>Nucleic Acids Res.</source>
<volume>45</volume>, <fpage>D566</fpage>&#x02013;<lpage>D573</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkw1004</pub-id>, PMID: <pub-id pub-id-type="pmid">27789705</pub-id>
</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Molecular characterization of Carbapenem-resistant <italic>Enterobacter cloacae</italic> in 11 Chinese cities</article-title>. <source>Front. Microbiol.</source>
<volume>9</volume>:<fpage>1597</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2018.01597</pub-id><pub-id pub-id-type="pmid">30065717</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karvelis</surname><given-names>T.</given-names></name><name><surname>Druteika</surname><given-names>G.</given-names></name><name><surname>Bigelyte</surname><given-names>G.</given-names></name><name><surname>Budre</surname><given-names>K.</given-names></name><name><surname>Zedaveinyte</surname><given-names>R.</given-names></name><name><surname>Silanskas</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease</article-title>. <source>Nature</source>
<volume>599</volume>, <fpage>692</fpage>&#x02013;<lpage>696</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-021-04058-1</pub-id>, PMID: <pub-id pub-id-type="pmid">34619744</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korczak</surname><given-names>L.</given-names></name><name><surname>Majewski</surname><given-names>P.</given-names></name><name><surname>Iwaniuk</surname><given-names>D.</given-names></name><name><surname>Sacha</surname><given-names>P.</given-names></name><name><surname>Matulewicz</surname><given-names>M.</given-names></name><name><surname>Wieczorek</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>Molecular mechanisms of tigecycline-resistance among Enterobacterales</article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>14</volume>:<fpage>1289396</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2024.1289396</pub-id>, PMID: <pub-id pub-id-type="pmid">38655285</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. Y.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Lv</surname><given-names>L.</given-names></name><name><surname>Jiao</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Emergence of the tigecycline resistance gene cluster tmexCD1-toprJ1 in an IncC plasmid and Citrobacter portucalensis</article-title>. <source>J. Antimicrob. Chemother.</source>
<volume>77</volume>, <fpage>2030</fpage>&#x02013;<lpage>2033</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkac136</pub-id>, PMID: <pub-id pub-id-type="pmid">35451006</pub-id>
</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papst</surname><given-names>L.</given-names></name><name><surname>Beovi&#x00107;</surname><given-names>B.</given-names></name><name><surname>Pulcini</surname><given-names>C.</given-names></name><name><surname>Durante-Mangoni</surname><given-names>E.</given-names></name><name><surname>Rodr&#x000ed;guez-Ba&#x000f1;o</surname><given-names>J.</given-names></name><name><surname>Kaye</surname><given-names>K. S.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Antibiotic treatment of infections caused by carbapenem-resistant gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals</article-title>. <source>Clin. Microbiol. Infect.</source>
<volume>24</volume>, <fpage>1070</fpage>&#x02013;<lpage>1076</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmi.2018.01.015</pub-id>, PMID: <pub-id pub-id-type="pmid">29410094</pub-id>
</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>Q.</given-names></name><name><surname>Kwon</surname><given-names>G. C.</given-names></name><name><surname>Koo</surname><given-names>S. H.</given-names></name></person-group> (<year>2020</year>). <article-title>Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant <italic>Klebsiella pneumoniae</italic> isolates</article-title>. <source>J. Clin. Lab. Anal.</source>
<volume>34</volume>:<fpage>e23506</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jcla.23506</pub-id>, PMID: <pub-id pub-id-type="pmid">32815626</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzin</surname><given-names>A.</given-names></name><name><surname>Immermann</surname><given-names>F. W.</given-names></name><name><surname>Bradford</surname><given-names>P. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>52</volume>, <fpage>3430</fpage>&#x02013;<lpage>3432</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00591-08</pub-id>, PMID: <pub-id pub-id-type="pmid">18625776</pub-id>
</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Ning</surname><given-names>Q.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease</article-title>. <source>Ann. Clin. Microbiol. Antimicrob.</source>
<volume>22</volume>:<fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12941-023-00560-8</pub-id>, PMID: <pub-id pub-id-type="pmid">36710337</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakris</surname><given-names>A.</given-names></name><name><surname>Poulou</surname><given-names>A.</given-names></name><name><surname>Pournaras</surname><given-names>S.</given-names></name><name><surname>Voulgari</surname><given-names>E.</given-names></name><name><surname>Vrioni</surname><given-names>G.</given-names></name><name><surname>Themeli-Digalaki</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates</article-title>. <source>J. Antimicrob. Chemother.</source>
<volume>65</volume>, <fpage>1664</fpage>&#x02013;<lpage>1671</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkq210</pub-id>, PMID: <pub-id pub-id-type="pmid">20542902</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="other">"<person-group person-group-type="author"><collab id="coll2">US FDA</collab></person-group>." (<year>2013</year>). Tygacil (Tigecycline). Available online at: <ext-link xlink:href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021821s026s031lbl.pdf" ext-link-type="uri">https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021821s026s031lbl.pdf</ext-link>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duin</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Carbapenem-resistant Enterobacteriaceae: what we know and what we need to know</article-title>. <source>Virulence</source>
<volume>8</volume>, <fpage>379</fpage>&#x02013;<lpage>382</lpage>. doi: <pub-id pub-id-type="doi">10.1080/21505594.2017.1306621</pub-id>, PMID: <pub-id pub-id-type="pmid">28402724</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duin</surname><given-names>D.</given-names></name><name><surname>Doi</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>The global epidemiology of carbapenemase-producing Enterobacteriaceae</article-title>. <source>Virulence</source>
<volume>8</volume>, <fpage>460</fpage>&#x02013;<lpage>469</lpage>. doi: <pub-id pub-id-type="doi">10.1080/21505594.2016.1222343</pub-id>, PMID: <pub-id pub-id-type="pmid">27593176</pub-id>
</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veleba</surname><given-names>M.</given-names></name><name><surname>Higgins</surname><given-names>P. G.</given-names></name><name><surname>Gonzalez</surname><given-names>G.</given-names></name><name><surname>Seifert</surname><given-names>H.</given-names></name><name><surname>Schneiders</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Characterization of RarA, a novel AraC family multidrug resistance regulator in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>56</volume>, <fpage>4450</fpage>&#x02013;<lpage>4458</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.00456-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22644028</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.-Z.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Q.-W.</given-names></name><name><surname>Lv</surname><given-names>L.-C.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>A novel transferable resistance-nodulation-division pump gene cluster, tmexCD2-toprJ2, confers Tigecycline resistance in <italic>Raoultella ornithinolytica</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>65</volume>:<fpage>e02229-20</fpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02229-20</pub-id><pub-id pub-id-type="pmid">33495220</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Zeling</surname><given-names>X.</given-names></name><name><surname>Lv</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>Promoter regulatory mode evolution enhances the high multidrug resistance of tmexCD1-toprJ1</article-title>. <source>MBio</source>
<volume>15</volume>:<fpage>e0021824</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mbio.00218-24</pub-id>, PMID: <pub-id pub-id-type="pmid">38564664</pub-id>
</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>The plasmid-borne tet(A) gene is an important factor causing Tigecycline resistance in ST11 Carbapenem-resistant <italic>Klebsiella pneumoniae</italic> under selective pressure</article-title>. <source>Front. Microbiol.</source>
<volume>12</volume>:<fpage>644949</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.644949</pub-id><pub-id pub-id-type="pmid">33717043</pub-id>
</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaghoubi</surname><given-names>S.</given-names></name><name><surname>Zekiy</surname><given-names>A. O.</given-names></name><name><surname>Krutova</surname><given-names>M.</given-names></name><name><surname>Gholami</surname><given-names>M.</given-names></name><name><surname>Kouhsari</surname><given-names>E.</given-names></name><name><surname>Sholeh</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source>
<volume>41</volume>, <fpage>1003</fpage>&#x02013;<lpage>1022</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10096-020-04121-1</pub-id>, PMID: <pub-id pub-id-type="pmid">33403565</pub-id>
</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Peng</surname><given-names>K.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Xia</surname><given-names>Z.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>Conjugative plasmids facilitate the transmission of tmexCD2-toprJ2 among carbapenem-resistant <italic>Klebsiella pneumoniae</italic></article-title>. <source>Sci. Total Environ.</source>
<volume>906</volume>:<fpage>167373</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.scitotenv.2023.167373</pub-id><pub-id pub-id-type="pmid">37758131</pub-id>
</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Lingfei</surname><given-names>H.</given-names></name><name><surname>Jing</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Novel chromosome-borne accessory genetic elements carrying multiple antibiotic resistance genes in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>11</volume>:<fpage>638087</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2021.638087</pub-id>, PMID: <pub-id pub-id-type="pmid">33816340</pub-id>
</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Cui</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Tigecycline sensitivity reduction in <italic>Escherichia coli</italic> due to widely distributed tet(A) variants</article-title>. <source>Microorganisms</source>
<volume>11</volume>:<fpage>3000</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms11123000</pub-id><pub-id pub-id-type="pmid">38138144</pub-id>
</mixed-citation></ref></ref-list></back></article>